ADH5 and lung carcinoma: Furthermore, evidence of dramatically decreased GSNOR expression was rare in the tested lung cancer samples; only 3 of the tumor samples were found with GSNOR expression decreased by more than 3-fold (ratio <0.33; Figure 5).